Medscape16h
Urine Dipstick Shows Higher Accuracy Than Laboratory Analysis for UTI Detection in Febrile Infants
Urine dipstick demonstrates higher sensitivity and specificity than laboratory urinalysis for diagnosing urinary tract ...
FDA approves new UTI antibiotic that may help patients with recurring infections
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
GSK's Blujepa Approved For Treatment of UTIs in Women, Children
GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...
Medscape3d
Pediatric Urinary Tract Infections
US and MCUG for all children aged <2 years. 99m Tc–DMSA scan in high-grade reflux [3] Urinary tract infection (UTI) is the most common serious bacterial infection in childhood, and its ...
FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
Morningstar3d
GSK's Blujepa Approved For Treatment of UTIs in Women, Children
GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...
FDA Approves New Oral Antibiotic Blujepa For UTI Treatment In Women And Teens
The FDA has approved Blujepa (gepotidacin), a first-in-class oral antibiotic for uncomplicated urinary tract infections (uUTIs) in women and children aged 12 and older. Clinical trials showed its ...
GlobalData on MSN2d
FDA approves GSK’s Blujepa for uncomplicated UTIs
The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for ...
The Independent2d
FDA approves new UTI antibiotic that may help patients with recurring infections
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children over the age of 12 with uncomplicated UTIs caused by bacteria including E.
HealthDay on MSN2d
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...
Morningstar3d
GSK's Treatment for Uncomplicated Urinary Tract Infections Approved in U.S.
GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic for the treatment of female adults and children with uncomplicated urinary tract infections. The pharmaceutical ...